WORKSHOP A: Think Tank on State and Federal Pharmaceutical IP Antitrust Initiatives: Patent Settlements, Reverse Payments, and Emerging Legislation

Aug 19, 2020 8:30am – 11:30am

(Registration starts at 7:30AM – Breakfast will be served)

  • Highlighting the nation’s first state legislation directly addressing purported “reverse payment” patent settlements
  • Reviewing the proper standards of antitrust review and the rising call for a legislative response
    • Analyzing the current legislative and regulatory framework
    • Mergers, acquisitions and exclusive licenses
    • Anticompetitive agreements
    • Abuse of dominance
    • Life cycle management and contracting
    • Pricing strategies
  • Avoiding costly litigation and associated penalties by effectively complying with the law
  • Evaluating the recent FTC reporting findings that detail fewer anticompetitive deals in PIV settlements
  • Reviewing biosimilars in the antitrust context
    • Understanding settlement strategies between innovator biologic companies and biosimilar applicants
    • Whether biologic manufacturers should expect antitrust scrutiny